Amiodarone in atrial fibrillation
Sir, The study reported by Kreiss and co-workers 1 is a major step in endorsing as good practice what junior doctors have been doing for sometime when faced with a heart failure patient in atrial fibrillation (AF), when the duty anaesthetist is unwilling to administer a general anaesthetic for electrical cardioversion. My only criticism is the implied message that the success rate of chemical cardioversion with amiodarone by the oral route, might be unacceptably low when attempted >48 hours after onset of AF. For such patients, the success rate of an exclusively oral regime has been shown to be of the order of 31%.
2 I have successfully cardioverted 16 out of 54 patients with amiodarone in the past 10 years, aged between 73 and 91 years (nine women), who illustrate the point that AF, documented on at least two occasions, more than 48 hours before initiation of antiarrhythmic therapy, can be converted to sinus rhythm with amiodarone, with no relapse on follow-up of up to 5 years. Prior to amiodarone, the duration of AF was 4-35 days in eight patients, 8-22 weeks in five patients, one year each in two patients, and 3 years 4 months in the final patient. After receiving a standardised loading dose (most of which was administered on an out-patient basis) of amiodarone 600 mg/day for 7 days, followed by 400 mg/day for 7 days, with a subsequent maintenance dose of 200 mg/day, cardioversion was documented by electrocardiography at variable times, ranging from <14 days (five cases) to periods of up to nine and a half months (11 cases), depending on when the patient could attend for follow-up. Subsequent to successful cardioversion, seven patients have remained in sinus rhythm during follow-up lasting 1-5 years, whilst in another nine, follow-up in sinus rhythm has been of <1 year duration. One case strikingly illustrates the risk/benefit profile of warfarin vs chemical cardioversion with amiodarone, even when the latter is commenced after 48 hours. This was a 74-year-old woman who commenced warfarin as well as amiodarone after a transient ischaemic attack occurring after five and a half months of established AF. Whist on warfarin, she experienced a nearfatal anaphylactic reaction to a 500 µg dose of intravenous vitamin K (Konakion Roche), 3 administered for correction of a prolonged International Normalised Ratio (INR). As a result of this mishap, instead of using the intravenous route, a subsequent INR of 9.5 was corrected to 1.7, within 24 hours, through the use of a 5 mg dose of oral vitamin K. After 5 months treatment with 200 mg/day of amiodarone, this patient has recently reverted to sinus rhythm, and will shortly be stopping warfarin, thereby avoiding all the risks of long-term anticoagulation. This letter was shown to the authors who responded as follows:
Sir,
The main aim of our study was to prospectively examine the eYcacy and safety of intravenous amiodarone in recent onset atrial fibrillation (AF).
1 The study did not include patients with AF of more than 48 hours duration, and thus, we have not tried to directly imply any message about the eYcacy of amiodarone conversion in such patients. However, we agree with Dr Jolobe, that converting chronic AF with oral amiodarone is feasible, but should be administered after appropriate anticoagulation. Dr Jolobe's success rate of about 30% conversion is in accordance with previous published data on treatment of AF with amiodarone.
2 Moreover, as shown in our data, we achieved similar results, as continued oral amiodarone loading for one month was successful in 3/9 patients.
1 However, it should be noted that intravenous amiodarone, but not oral loading, has an immediate eVect on slowing the ventricular response rate, as we and others have shown. Thus, the indications and the risk-benefit ratio are diVerent for intravenous vs oral amiodarone.
Book reviews
The reviewers have been asked to rate these books in terms of four items: readibility, how up-to-date they are, accuracy and reliability, and value for money, using simple four-point scales. Pulse oximeters, like smoke alarms and carbon monoxide detectors, are late 20th century devices which many of us would feel naked working without. They monitor noninvasively and in real-time to warn of unseen changes in oxygenation and perfusion, as near-perfect end-organ observers. Their presence, outlined in this book, in various hostile environments or where sedation is practised, has been particularly welcomed by medical staV everywhere.
The author John Moyle, an engineer and anaesthetist/intensivist, is a gifted, concise writer. This second edition details clinical and physical matters with equal clarity and includes a new chapter on foetal oximetry, where trends in (already low) saturations correlate well with sampling as reasonable predictors of outcome or to advise on the timing of interventions.
His well-referenced text should be available to all new and existing users of these devices. Whilst sensitive to the rights of publishers, it would be wonderful if instrument manufacturers would bulk-buy and distribute this book with their products! A good buy nonetheless. This book provides a detailed description and assessment of all aspects of health services research. The first two sections describe how health and disease can be measured and the types of study designs available to test new interventions and technologies. Examples of topics included are disease-specific measurement scores, quality-of-life measures, the merits of both randomised and nonrandomised trials as well as their ethical and social issues. The book continues by giving an overview of statistical approaches and how data should be presented and interpreted. Examples include the Bayesian approach and survival data. The final section discusses future developments including how to identify new technologies and their implementation. The research structure within the NHS is also described. This is an excellent book which is clearly written and covers all the disciplines within the field. The principles outlined are complemented by many examples from clinical practice. The chapters are well illustrated with summary boxes and relevant diagrams. Each chapter is written by a group of authors who are all leaders in their area. This book will be invaluable to those new to the field who wish to gain an overview as well as to the more experienced worker wishing to gain more detailed information on a particular area. I am sure this book is going to become the definitive text in its field. PO Box 1925 , Roswell, GA 30077-1925 fax +1 770 552 9859 
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